Further evidence of a clinically significant levofloxacin-warfarin interaction.
Glasheen
Jeffrey J
JJ
Prochazka
Allan V
AV
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D019934:International Normalized Ratio; D064704:Levofloxacin; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014859:Warfarin; D064704:Levofloxacin; D015242:Ofloxacin